| Literature DB >> 31727103 |
Peng Liu1, Liqin Yang1, Jingyue Zhang1, Tao Wang1, Yuanyuan Wu1, Mingshu Wang1,2,3, Renyong Jia1,2,3, Dekang Zhu2,3, Mafeng Liu1,2,3, Xinxin Zhao1,2,3, Qiao Yang1,2,3, Ying Wu1,2,3, Shaqiu Zhang1,2,3, Yunya Liu1,2,3, Yanling Yu1,2,3, Ling Zhang1,2,3, Leichang Pan1,2,3, Shun Chen4,5,6, Anchun Cheng7,8,9.
Abstract
BACKGROUND: Goose parvovirus (GPV) is the etiological agent of Derzsy's disease and is fatal for gosling. Research on the molecular basis of GPV pathogenicity has been hampered by the lack of a reliable reverse genetics system. At present, the GPV infectious clone has been rescued by transfection in the goose embryo, but the growth character of it is unclear in vitro.Entities:
Keywords: GEF; GPV; Infectious clone; NLS; Proliferation
Mesh:
Substances:
Year: 2019 PMID: 31727103 PMCID: PMC6854815 DOI: 10.1186/s12985-019-1237-2
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
The oligonucleotide primer used for amplification of GPV RC16 genome in this study
| Primer | The sequence (5′-3′) |
|---|---|
| A1F | TCATTGGAGGGTTCGTTCGTTC |
| A1R | CATGCGCGCGGTCAACCTAACAGCCG |
| A2F | CGCGCGGTCAGCCCAATAGTTAAGCC |
| A2R | CTTCCTGGCGCGCAAAATATC |
| A3F | GATATTTTGCGCGCCAGGAAG |
| A3R | GAGGGGCTCCAGCTTTCAGATTCC |
| A4F | CGGAATCTGAAAGCTGGAGC |
| A4R | CTAAAATATTTTGGGCTGGGATGC |
| A5F | TCAGCTACTCACACAGAAG |
| A5R | CATGCGCGCGGTCAGCCCAATAG |
| A6F | CGCGCGGTCAACCTAACAGCCGG |
| A6R(A1F) | TCATTGGAGGGTTCGTTCGTTC |
The oligonucleotide primer used for construction of GPV RC16 infectious clone in this study
| Primer | The sequence (5′-3′) |
|---|---|
| pACA1F | |
| pACA1R | |
| pACA2F | GTTAGGTTGACCGCGCGCATGCGCGCGGTCAGCCC |
| pACA2R) | |
| pACA3F | GATATTTTGCGCGCCAGGAAGTGACGTGCAATGCCAC |
| pACA3R | |
| pACA4F | AAAGCTGGAGCCCCTCACCCAAAACCAAACCAGCAGACTCAG |
| pACA4R | |
| pACA5F | CCAGCCCAAAATATTTTAGGTTTAGCTAAAGATC |
| pACA5R | |
| pACA6F | CTTAACTATTGGGCTGGACCGCGCGCATGCG |
| pACA6R |
The region of plasmid vector was indicated by underline
The DNA fragments used for construction of GPV RC16 infectious clone with mutated NLS site in this study
| DNA fragments | The sequence (5′-3′) |
|---|---|
| K164A | GCAAAAAAAAATACAGGGAAGCTTACCGACCACTACCCGGTAGTT |
| K165A | GCAAAAAAAAATACAGGGAAGCTTACCGACCACTACCCGGTAGTTAAG |
| K167A | GCAAAAAAAAATACAGGGAAGCTTACCGACCACTACCCGGTAGTTAAGAAGCCT |
| AAPA | GCAAAAAAAAATACAGGGAAGCTTACCGACCACTACCCGGTAGTT |
| KKRK | GCAAAAAAAAATACAGGGAAGCTTACCGACCACTACCCGGTAGTTAAGAAG |
The mutated sites were indicated by underline
Fig. 1Phylogenetic analysis. The phylogenetic trees were constructed based on the amino acid sequence of Rep1 (a) and VP1 (b) by using the neighbor-joining method in MEGA 6.0
Fig. 2The construction of GPV RC16 reverse genetics strategy. a Six pair primers had been designed to amplify the complete genome based on the genome of the GPV YZ99–6 strain. The amplified fragments were A1, A2, A3, A4, A5, and A6, respectively. All fragments from A1 to A6 were orderly cloned into pACYC177. A genetic maker (M: AAGCTT→GAGTTT) was introduced into the site 1265 and 1268. b The amplified six fragments have been identified by Electrophoresis
Fig. 3Identification of the recombinant GPV. a The expressions of Rep1 and capsid proteins had been identified at F0, F1, and F2 of pIRC16. b The amplified A3 from the rGPV RC16 F2 and the parental GPV RC16 had been digested by HindIII, while the A3 from GPV RC16 could be digested to two fragments of 1.2 kb and 0.8 kb by HindIII resulting in. c The amplified A3 had been sequenced and the genetic maker had been verified
Fig. 4The recombinant GPV proliferated well in GEF. a IFA of GEF cells infected with the rGPV RC16 F2 as detected using the mouse anti-GPV polyclonal antibody and the rabbit anti-GPV Rep polyclonal antibody. b The expression of GPV Rep1 from the rGPV RC16 F2 was detected by WB using the rabbit anti-GPV Rep polyclonal antibody from 24 h to 120 h
Fig. 5The 164 K, 165 K, and 167 K are vital for GPV proliferation. a Construction and transfection of pIRC16 K164A, pIRC16 K165A, pIRC16 K167A, pIRC16 AAPA and pIRC16 KKRK. On one hand, the cells were collected to detect the expression level of GPV Rep by IFA and WB at 72 h post-transfection. F0 represents the virus transfected pIRC16 K164A, pIRC16 K165A, pIRC16 K167A, pIRC16 AAPA, and pIRC16 KKRK respectively. On the other hand, the cells were collected to infect GEFs at 72 h post-transfection. F1 represents the virus from passaged F0. b and (d) At 72 h post-transfection, the GPV Rep of F0 was detected by IFA and WB using the rabbit anti-GPV Rep polyclonal antibody. c and (e) At 72 h PI, the GPV Rep of F1 was detected by IFA and WB using the rabbit anti-GPV Rep polyclonal antibody
Fig. 6The GPV capsid with mutated 164 K, 165 K or 167 K of VP1 can enter into the nucleus. At 72 h post-transfection with pIRC16 K164A, pIRC16 K165A, pIRC16 K167A, pIRC16 AAPA, pIRC16 KKRK and pIRC16, the capsid protein could be detected in the nucleus by IFA using mouse anti-GPV capsid polyclonal antibody